Key points from this week’s report:
• The MSCI Asia ex. Japan index (AAXJ) breached its 21-DMA support after facing resistance along its 50-DMA. It is still
trading 24% off highs.
• India and Indonesia are in a Confirmed Uptrend. Seven markets, including South Korea, China, Hong Kong, Japan and
Taiwan, are in an Uptrend Under Pressure. Four markets, including Australia, are in a Rally Attempt.
• The MSCI Asia Pacific growth index has underperformed the value index over the last 52-weeks. The spread between
growth and value hit a 52-week low in March, before it increased in late-March when major indices were bouncing off
lows. However, the spread is pulling back to March lows, which is near pre-pandemic levels.
• We are yet to see evidence for an improvement in quality growth names over value names. Over the past month, quality
growth stocks outperformed value as they had a strong bounce from oversold levels. However, over the past week, growth
stocks have pulled back harder compared with value stocks. We recommend investors remain patient and avoid buying
dips.
• Highlighted Focus List Idea: Astellas Pharma (YP@N.JP; 4503 JP).